LIVIVO - Das Suchportal für Lebenswissenschaften

switch to English language
Erweiterte Suche

Suchergebnis

Treffer 1 - 10 von insgesamt 57

Suchoptionen

  1. Artikel ; Online: Is multisystem inflammatory syndrome in children on the Kawasaki syndrome spectrum?

    Yeung, Rae Sm / Ferguson, Polly J

    The Journal of clinical investigation

    2020  Band 130, Heft 11, Seite(n) 5681–5684

    Abstract: An alarming increase in children presenting with fever, hyperinflammation, and multiorgan dysfunction frequently requiring intensive care has been observed after severe acute respiratory syndrome coronavirus 2 infection. The illness resembles Kawasaki ... ...

    Abstract An alarming increase in children presenting with fever, hyperinflammation, and multiorgan dysfunction frequently requiring intensive care has been observed after severe acute respiratory syndrome coronavirus 2 infection. The illness resembles Kawasaki disease (KD), with coronary dilatation and aneurysm occurring in some. However, the cardiovascular manifestations were typically on the severe end of the KD spectrum, with cardiogenic shock a common presentation together with other features. This led to defining a unique syndrome named multisystem inflammatory syndrome in children (MIS-C). In this issue of the JCI, Lee and Day-Lewis et al. and Diorio et al. explored the clinical profiles associated with coronavirus disease 2019 in children. We posit that while splitting MIS-C into a separate disease may aid clinical management decisions, lumping it into the KD pot may better serve to understand pathobiology.
    Mesh-Begriff(e) Betacoronavirus ; COVID-19 ; Child ; Coronavirus Infections ; Humans ; Mucocutaneous Lymph Node Syndrome/complications ; Pandemics ; Pneumonia, Viral ; SARS-CoV-2 ; Systemic Inflammatory Response Syndrome
    Schlagwörter covid19
    Sprache Englisch
    Erscheinungsdatum 2020-07-30
    Erscheinungsland United States
    Dokumenttyp Journal Article ; Comment
    ZDB-ID 3067-3
    ISSN 1558-8238 ; 0021-9738
    ISSN (online) 1558-8238
    ISSN 0021-9738
    DOI 10.1172/JCI141718
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  2. Artikel ; Online: [Titelangabe fehlt]

    Tam, Herman / El Tal, Tala / Go, Ellen / Yeung, Rae Sm

    CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne

    2020  Band 192, Heft 48, Seite(n) E1686–E1690

    Titelübersetzung Le syndrome inflammatoire multisystémique de l’enfant ayant un lien temporel avec la COVID-19 : multiples visages, multiples appellations.
    Sprache Französisch
    Erscheinungsdatum 2020-11-20
    Erscheinungsland Canada
    Dokumenttyp Journal Article
    ZDB-ID 215506-0
    ISSN 1488-2329 ; 0008-4409 ; 0820-3946
    ISSN (online) 1488-2329
    ISSN 0008-4409 ; 0820-3946
    DOI 10.1503/cmaj.201600-f
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  3. Artikel ; Online: Long-term use and remission of granulomatosis with polyangiitis with the oral C5a receptor inhibitor avacopan.

    Ennis, Daniel / Yeung, Rae Sm / Pagnoux, Christian

    BMJ case reports

    2020  Band 13, Heft 10

    Abstract: Granulomatosis with polyangiitis (GPA) is a rare antineutrophil cytoplasm antibody-associated vasculitis. Several therapeutic advances have occurred over the past two decades, but relapse rate remains high and refractory cases are not uncommon. Here, we ... ...

    Abstract Granulomatosis with polyangiitis (GPA) is a rare antineutrophil cytoplasm antibody-associated vasculitis. Several therapeutic advances have occurred over the past two decades, but relapse rate remains high and refractory cases are not uncommon. Here, we present the case of a female patient diagnosed with GPA at the age of 9 years with a severe, multirelapsing disease course which failed to adequately respond to conventional therapies. Avacopan, a novel C5a receptor inhibitor, was started based on phase II studies that showed promise as a steroid-sparing adjunct. The patient was able to successfully reduce her glucocorticoid dose and reduce her immunosuppressive treatments without another flare. She has been on avacopan for 35 months, had no adverse events that required its discontinuation, and her disease is in sustained remission.
    Mesh-Begriff(e) Administration, Oral ; Aniline Compounds/administration & dosage ; Child ; Dose-Response Relationship, Drug ; Female ; Follow-Up Studies ; Granulomatosis with Polyangiitis/diagnosis ; Granulomatosis with Polyangiitis/drug therapy ; Humans ; Nipecotic Acids/administration & dosage ; Receptor, Anaphylatoxin C5a/antagonists & inhibitors ; Remission Induction/methods ; Time Factors ; Tomography, X-Ray Computed ; Treatment Outcome
    Chemische Substanzen Aniline Compounds ; Nipecotic Acids ; Receptor, Anaphylatoxin C5a ; avacopan (O880NM097T)
    Sprache Englisch
    Erscheinungsdatum 2020-10-29
    Erscheinungsland England
    Dokumenttyp Case Reports ; Journal Article
    ISSN 1757-790X
    ISSN (online) 1757-790X
    DOI 10.1136/bcr-2020-236236
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  4. Artikel: Kawasaki disease: High index of suspicion needed in a febrile child.

    Scuccimarri, Rosie / Yeung, Rae Sm

    Paediatrics & child health

    2014  Band 19, Heft 5, Seite(n) 239–240

    Sprache Englisch
    Erscheinungsdatum 2014-05-07
    Erscheinungsland England
    Dokumenttyp Journal Article
    ZDB-ID 2106767-3
    ISSN 1918-1485 ; 1205-7088
    ISSN (online) 1918-1485
    ISSN 1205-7088
    DOI 10.1093/pch/19.5.239
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  5. Artikel: Is multisystem inflammatory syndrome in children on the Kawasaki syndrome spectrum?

    Yeung, Rae Sm / Ferguson, Polly J

    J Clin Invest

    Abstract: An alarming increase in children presenting with fever, hyperinflammation, and multiorgan dysfunction frequently requiring intensive care has been observed after severe acute respiratory syndrome coronavirus 2 infection. The illness resembles Kawasaki ... ...

    Abstract An alarming increase in children presenting with fever, hyperinflammation, and multiorgan dysfunction frequently requiring intensive care has been observed after severe acute respiratory syndrome coronavirus 2 infection. The illness resembles Kawasaki disease (KD), with coronary dilatation and aneurysm occurring in some. However, the cardiovascular manifestations were typically on the severe end of the KD spectrum, with cardiogenic shock a common presentation together with other features. This led to defining a unique syndrome named multisystem inflammatory syndrome in children (MIS-C). In this issue of the JCI, Lee and Day-Lewis et al. and Diorio et al. explored the clinical profiles associated with coronavirus disease 2019 in children. We posit that while splitting MIS-C into a separate disease may aid clinical management decisions, lumping it into the KD pot may better serve to understand pathobiology.
    Schlagwörter covid19
    Verlag WHO
    Dokumenttyp Artikel
    Anmerkung WHO #Covidence: #691305
    Datenquelle COVID19

    Kategorien

  6. Artikel ; Online: Evaluating the time-varying risk of hypertension, cardiac events, and mortality following Kawasaki disease diagnosis.

    Lee, Jennifer J Y / Feldman, Brian M / McCrindle, Brian W / Li, Ping / Yeung, Rae Sm / Widdifield, Jessica

    Pediatric research

    2022  Band 93, Heft 5, Seite(n) 1439–1446

    Abstract: Background: This study evaluated the risk of hypertension, major adverse cardiac events (MACE), and all-cause mortality in Kawasaki disease (KD) patients up to young adulthood.: Methods: An inception cohort of 1169 KD patients between 1991 and 2008 ... ...

    Abstract Background: This study evaluated the risk of hypertension, major adverse cardiac events (MACE), and all-cause mortality in Kawasaki disease (KD) patients up to young adulthood.
    Methods: An inception cohort of 1169 KD patients between 1991 and 2008 from a tertiary-level hospital in Ontario, Canada was linked with health administrative data to ascertain outcomes up to 28 years of follow-up. Their risk was compared with 11,690 matched population comparators. The primary outcome was hypertension and secondary outcomes were MACE and death.
    Results: After a median follow-up of 20 years [IQR: 8.3], the cumulative incidence of hypertension and MACE in the KD group was 3.8% (95% CI: 2.5-5.5) and 1.2% (95% CI: 0.6-2.4%), respectively. The overall survival probability in the KD group was 98.6% (95% CI: 97.2-99.3%). Relative to comparators, KD patients were at an increased risk for hypertension [aHR: 2.2 (95% CI: 1.5-3.4)], death [aHR: 2.5 (95% CI: 1.3-5.0)], and MACE [aHR: 10.7 (95% CI: 6.4-17.9)]. For hypertension and MACE, the aHR was the highest following diagnosis and then the excess risk diminished after 16 and 13 years of follow-up, respectively. MACE occurred largely in KD patients with coronary aneurysms [cumulative incidence: 12.8%].
    Conclusions: KD patients demonstrated a reassuring cardiac prognosis up to young adulthood with low events and excellent survival. KD patients were at increased risk for hypertension, but this excess risk occurred early and declined with time.
    Impact: With the current standard of care, KD patients demonstrated favorable cardiac prognosis, with low events of hypertension, MACE, and excellent survival. Hypertension and MACE risk appear to be highest around the time of KD diagnosis. MACE occurred primarily in KD patients with coronary aneurysms. Our findings are reassuring to KD patients, families, and their providers. Our study demonstrated an association between KD exposure and hypertension. This association is relatively novel. Previous studies have remained conflicting if KD contributes to long-term atherosclerotic risk.
    Mesh-Begriff(e) Humans ; Young Adult ; Adult ; Coronary Aneurysm/complications ; Coronary Aneurysm/diagnosis ; Mucocutaneous Lymph Node Syndrome/complications ; Mucocutaneous Lymph Node Syndrome/diagnosis ; Hypertension/complications ; Hypertension/diagnosis ; Incidence ; Ontario/epidemiology ; Risk Factors ; Retrospective Studies
    Sprache Englisch
    Erscheinungsdatum 2022-08-24
    Erscheinungsland United States
    Dokumenttyp Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 4411-8
    ISSN 1530-0447 ; 0031-3998
    ISSN (online) 1530-0447
    ISSN 0031-3998
    DOI 10.1038/s41390-022-02273-8
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  7. Artikel ; Online: The role of Inositol 1,4,5 triphosphate kinase C in the pathogenesis of Kawasaki disease

    Yeung Rae SM / Khajoee Vahid

    Pediatric Rheumatology, Vol 9, Iss Suppl 1, p P

    2011  Band 295

    Schlagwörter Diseases of the musculoskeletal system ; RC925-935 ; Specialties of internal medicine ; RC581-951 ; Internal medicine ; RC31-1245 ; Medicine ; R ; DOAJ:Internal medicine ; DOAJ:Medicine (General) ; DOAJ:Health Sciences ; Pediatrics ; RJ1-570 ; DOAJ:Pediatrics
    Sprache Englisch
    Erscheinungsdatum 2011-09-01T00:00:00Z
    Verlag BioMed Central
    Dokumenttyp Artikel ; Online
    Datenquelle BASE - Bielefeld Academic Search Engine (Lebenswissenschaftliche Auswahl)

    Zusatzmaterialien

    Kategorien

  8. Artikel ; Online: Reply.

    Aeschlimann, Florence A / Yeung, Rae S M / Barra, Lillian / Benseler, Susanne M

    Arthritis & rheumatology (Hoboken, N.J.)

    2019  Band 71, Heft 5, Seite(n) 836–838

    Mesh-Begriff(e) Adult ; Child ; Disease Progression ; Humans ; Takayasu Arteritis
    Sprache Englisch
    Erscheinungsdatum 2019-03-06
    Erscheinungsland United States
    Dokumenttyp Letter ; Comment
    ZDB-ID 2756371-6
    ISSN 2326-5205 ; 2326-5191
    ISSN (online) 2326-5205
    ISSN 2326-5191
    DOI 10.1002/art.40824
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  9. Artikel ; Online: Predictors of delayed treatment of Kawasaki disease in community and tertiary care hospitals

    Luca Nadia / Ching Joyce CY / Manlhiot Cedric / McCrindle Brian W / Yeung Rae SM

    Pediatric Rheumatology, Vol 10, Iss Suppl 1, p A

    2012  Band 89

    Schlagwörter Diseases of the musculoskeletal system ; RC925-935 ; Specialties of internal medicine ; RC581-951 ; Internal medicine ; RC31-1245 ; Medicine ; R ; DOAJ:Internal medicine ; DOAJ:Medicine (General) ; DOAJ:Health Sciences ; Pediatrics ; RJ1-570 ; DOAJ:Pediatrics
    Sprache Englisch
    Erscheinungsdatum 2012-07-01T00:00:00Z
    Verlag BioMed Central
    Dokumenttyp Artikel ; Online
    Datenquelle BASE - Bielefeld Academic Search Engine (Lebenswissenschaftliche Auswahl)

    Zusatzmaterialien

    Kategorien

  10. Artikel ; Online: What matters most to pediatric rheumatologists in deciding whether to discontinue biologics in a child with juvenile idiopathic arthritis? A best-worst scaling survey.

    Currie, Gillian R / Groothuis-Oudshoorn, Catherina G M / Twilt, Marinka / Kip, Michelle M A / IJzerman, Maarten J / Benseler, Susanne M / Swart, Joost F / Vastert, Sebastiaan J / Wulffraat, Nico M / Yeung, Rae / Marshall, Deborah A

    Clinical rheumatology

    2023  Band 42, Heft 8, Seite(n) 2173–2180

    Abstract: Objectives: Care for JIA patients has been transformed in the biologics era; however, biologics carry important (although rare) risks and are costly. Flares after biological withdrawal are seen frequently, yet there is little clinical guidance to ... ...

    Abstract Objectives: Care for JIA patients has been transformed in the biologics era; however, biologics carry important (although rare) risks and are costly. Flares after biological withdrawal are seen frequently, yet there is little clinical guidance to identify which patients in clinical remission can safely have their biologic discontinued (by stopping or tapering). We examined what characteristics of the child or their context are important to pediatric rheumatologists when making the decision to discuss withdrawal of biologics.
    Methods: We conducted a survey including a best-worst scaling (BWS) exercise in pediatric rheumatologists who are part of the UCAN CAN-DU network to assess the relative importance of 14 previously identified characteristics. A balanced incomplete block design was used to generate choice tasks. Respondents evaluated 14 choice sets of 5 characteristics of a child with JIA and identified for each set which was the most and least important in the decision to offer withdrawal. Results were analyzed using conditional logit regression.
    Results: Fifty-one (out of 79) pediatric rheumatologists participated (response rate 65%). The three most important characteristics were how challenging it was to achieve remission, history of established joint damage, and time spent in remission. The three least important characteristics were history of temporomandibular joint involvement, accessibility of biologics, and the patient's age.
    Conclusions: These findings give quantitative insight about factors important to pediatric rheumatologists' decision-making about biologic withdrawal. In addition to high quality clinical evidence, further research is needed to understand the perspective of patients and families to inform shared decision-making about biologic withdrawal for JIA patients with clinically inactive disease. Key Points ● What is already known on this topic-there is limited clinical guidance for pediatric rheumatologists in making decisions about biologic withdrawal for patients with juvenile idiopathic arthritis who are in clinical remission. ● What this study adds-this study quantitatively examined what characteristic of the child in clinical remission, or of their context, are most important to pediatric rheumatologists in deciding whether to offer withdrawal of biologics. ● How this study might affect research, practice or policy-understanding of these characteristics can provide useful information to other pediatric rheumatologists in making their decisions, and may guide areas to focus on for future research.
    Mesh-Begriff(e) Humans ; Child ; Arthritis, Juvenile/drug therapy ; Antirheumatic Agents/therapeutic use ; Rheumatologists ; Surveys and Questionnaires ; Biological Products/therapeutic use
    Chemische Substanzen Antirheumatic Agents ; Biological Products
    Sprache Englisch
    Erscheinungsdatum 2023-05-19
    Erscheinungsland Germany
    Dokumenttyp Journal Article
    ZDB-ID 604755-5
    ISSN 1434-9949 ; 0770-3198
    ISSN (online) 1434-9949
    ISSN 0770-3198
    DOI 10.1007/s10067-023-06616-6
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

Zum Seitenanfang